Network-meta analysis (NMA) is often an essential requirement for Health Technology Assessment (HTA) activities and allows the comparison of all relevant treatments within a disease area. SIRIUS Market Access conduct specialist network meta-analysis (NMA) feasibility studies for pharmaceutical and healthcare companies. NMA feasibility studies are essential for planning indirect treatment comparisons, economic models, and developing HTA strategies, particularly early on in drug development. We can conduct NMA feasibility studies based on our own systematic literature reviews, or on systematic literature reviews provided by our clients. SIRIUS Market Access produce NMAs which meet HTA criteria, and are publishable in peer review journals.
At SIRIUS, we work with our clients to deliver high quality NMAs and feasibility studies that take into account the characteristics of clinical trial data and the wider disease area. Our NMAs are highly regarded by our clients and are used for broader activities relating to evidence generation and market access strategy development.
If you’re interested in working with SIRIUS, please get in touch using the CONTACT page.